NM_000396.4:c.721C>T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000396.4(CTSK):c.721C>T(p.Arg241*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R241R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000396.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152136Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251476Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135916
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.0000701 AC XY: 51AN XY: 727242
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74318
ClinVar
Submissions by phenotype
Pyknodysostosis Pathogenic:9
- -
- -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.007%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000008422 /PMID: 8703060). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
ACMG classification criteria: PVS1 very strong, PS4 strong, PM2 supporting, PM3 very strong, PP1 strong -
- -
- -
The stop gained p.R241* in CTSK (NM_000396.4) has been observed in individuals affected with pycnodysostosis, and has been shown to segregate with disease in a family (B D Gelb et al; M R Johnson). It is expected to result in an absent or disrupted protein product. The variant has been reported to ClinVar as Pathogenic/Likely Pathogenic. This variant is predicted to cause loss of normal protein function through protein truncation. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg241*) in the CTSK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTSK are known to be pathogenic (PMID: 12125807, 21569238). This variant is present in population databases (rs74315303, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with pycnodysostosis (PMID: 8703060, 8938428). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 8422). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at